Winchester Group’s Amgen AMGN Stock Holding History

Winchester Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$1.87M	Hold	16,720	–	–	0.41%	68
2013 Q2	$1.65M	Buy	+16,720	New	+$1.74M	0.35%	72

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Winchester Group's AMGN Position: Q3 2013 in Review

Winchester Group held its Amgen (AMGN) position steady in Q3 2013 at 16,720 shares worth $1.87M. The position accounts for 0.41% of the portfolio, ranked #68.

Winchester Group first reported a position in AMGN in Q2 2013 and has held it in 2 quarters since. 1,062 funds tracked by Wall St. Rank hold AMGN as of Q3 2013.

Winchester Group held 16,720 shares of Amgen worth $1.87M as of Q3 2013.
Winchester Group left its Amgen share count unchanged in Q3 2013.
Amgen made up 0.41% of Winchester Group's portfolio in Q3 2013, its #68 holding.
Winchester Group first reported a position in Amgen in Q2 2013 and has held it in 2 quarters since.
1,062 funds tracked by Wall St. Rank held Amgen as of Q3 2013.

Based on Winchester Group's 13F filing for Q3 2013, filed 16 Oct 2013.